Tirzepatide Prescribing at TOWER HOUSE PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
737
Total Quantity
742
NHS Cost
£69.4K
vs National Avg
+279.5%
TOWER HOUSE PRACTICE prescribed 737 items of Tirzepatide over the last 12 months at a cost of £69,413 to the NHS. This is 279.5% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
19
Jun 2026
29
Jun 2026
34
Jun 2026
47
Jun 2026
47
Jun 2026
65
Jun 2026
69
Jun 2026
84
Jun 2026
78
Jun 2026
78
Jun 2026
91
Jun 2026
96
Prescribing Details
| Total Items | 737 |
|---|---|
| Total Quantity | 742 |
| Total NHS Cost | £69,413 |
| Presentations | 8 different forms |
| vs National Average | +279.5% |
Tirzepatide Prescribing Comparison
| This practice | 737 items |
|---|---|
| National average per practice | 194 items |
| Difference | +279.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.